Even though SRRM2 CAR-T cells were unable to eliminate the xenografted tumor cells completely, we observed that even a single injection of CAR-T cells showed a clear antitumor activity resulting in significant tumor growth delay. This evidence concerns the gene SRRM2 and neoplasm.